Higashi Hisato, Shida Haruhiko, Ban Kanako, Yamagata Seiichi, Masuda Kozo, Imanari Tomohiro, Yamamoto Takashi
Department of Surgery, Tokyo Kosei Nenkin Hospital, Tokyo, Japan.
Jpn J Clin Oncol. 2003 Jul;33(7):357-9. doi: 10.1093/jjco/hyg061.
Nonresectable colorectal cancer often causes malignant intestinal obstruction due to peritoneal dissemination. However, no previous report has specifically investigated which patients, with peritoneal dissemination from colorectal cancer, would actually benefit from palliative surgery. This study defines the selection criteria for patients who are likely to benefit from palliative surgery.
Twenty-one patients underwent palliative surgery for malignant bowel obstruction due to peritoneal dissemination from colorectal cancer. In all cases, the advanced and nonresectable nature of the tumor was confirmed at laparotomy. Clinical factors such as age, gender, serum level of carcinoembryonic antigen, amount of ascites, location of the primary cancer, surgical procedure, and postoperative chemotherapy were analyzed for prognostic significance in symptom-free and overall survival using the Kaplan-Meier product limit method and the log-rank test.
All the postoperative courses were uneventful. Obstruction recurred after a median symptom-free interval of 61 days in the group with less than 100 ml of ascites, whereas it recurred after 9 days in the group with more than 100 ml of ascites. Symptom-free survival rates in patients who manifested ascites were significantly lower than in those without ascites (P = 0.0321, log-rank method). The symptom-free and overall survival rates in patients who underwent postoperative chemotherapy were significantly higher (P = 0.0225 and 0.0003).
Palliative surgery can be performed effectively for patients without ascites. For patients who do not meet this criterion, a non-surgical procedure may be preferable.
不可切除的结直肠癌常因腹膜播散导致恶性肠梗阻。然而,此前尚无报告专门研究哪些因结直肠癌腹膜播散的患者实际上会从姑息性手术中获益。本研究确定了可能从姑息性手术中获益的患者的选择标准。
21例患者因结直肠癌腹膜播散导致的恶性肠梗阻接受了姑息性手术。所有病例均在剖腹手术中证实肿瘤为晚期且不可切除。使用Kaplan-Meier乘积限法和对数秩检验分析年龄、性别、癌胚抗原血清水平、腹水量、原发癌位置、手术方式和术后化疗等临床因素对无症状生存期和总生存期的预后意义。
所有术后病程均顺利。腹水量少于100 ml的组中位无症状间隔61天后梗阻复发,而腹水量多于100 ml的组9天后梗阻复发。有腹水的患者无病生存率显著低于无腹水的患者(P = 0.0321,对数秩检验)。接受术后化疗的患者无病生存率和总生存率显著更高(P = 0.0225和0.0003)。
对于无腹水的患者,可有效进行姑息性手术。对于不符合该标准的患者,非手术治疗可能更可取。